2023 Articles
Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson’s disease and multiple system atrophy
Synucleinopathies are neurodegenerative diseases characterized by accumulation of misfolded α-synuclein (α-syn) inclusions in neuronal and/or glial cells. Despite differences in the underlying pathophysiology, synucleinopathies often are misdiagnosed, especially in early stages, due to the overlapping clinical symptoms [1].
Subjects
Files
- 40035_2023_Article_346.pdf application/pdf 194 KB Download File
Also Published In
- Title
- Translational Neurodegeneration
- DOI
- https://doi.org/10.1186/s40035-023-00346-0
More About This Work
- Published Here
- July 22, 2024